Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | cathepsin b | 0.0148 | 0.2724 | 0.2724 |
Loa Loa (eye worm) | hypothetical protein | 0.043 | 0.957 | 1 |
Brugia malayi | calpain family protein 1 | 0.0117 | 0.1983 | 0.2073 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0148 | 0.2724 | 1 |
Echinococcus multilocularis | calpain 7 (C02 family) | 0.0044 | 0.0209 | 0.0209 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0123 | 0.2112 | 0.2112 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0044 | 0.0209 | 0.0767 |
Brugia malayi | calpain 7 | 0.0044 | 0.0209 | 0.0218 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0117 | 0.1983 | 0.7281 |
Echinococcus multilocularis | neuropeptide s receptor | 0.0448 | 1 | 1 |
Brugia malayi | Voltage-gated calcium channel, T-type, alpha subunit. C. elegans cca-1 ortholog | 0.0172 | 0.3313 | 0.3462 |
Onchocerca volvulus | 0.043 | 0.957 | 1 | |
Trichomonas vaginalis | conserved hypothetical protein | 0.0168 | 0.3199 | 1 |
Echinococcus multilocularis | hypothetical protein | 0.0044 | 0.0209 | 0.0209 |
Leishmania major | cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like | 0.0049 | 0.0319 | 1 |
Giardia lamblia | Cathepsin B precursor | 0.0049 | 0.0319 | 0.5 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0044 | 0.0209 | 0.0767 |
Giardia lamblia | Cathepsin B precursor | 0.0049 | 0.0319 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0073 | 0.0909 | 0.0949 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0036 | 0 | 0.5 |
Echinococcus multilocularis | Protein lozenge | 0.0054 | 0.0443 | 0.0443 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0049 | 0.0319 | 0.1171 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0148 | 0.2724 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0148 | 0.2724 | 0.2847 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0044 | 0.0209 | 0.0767 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0044 | 0.0209 | 0.0767 |
Echinococcus granulosus | cathepsin b | 0.0148 | 0.2724 | 0.2724 |
Echinococcus granulosus | calpain 5 | 0.0044 | 0.0209 | 0.0209 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0044 | 0.0209 | 0.0767 |
Schistosoma mansoni | calpain-7 (C02 family) | 0.0044 | 0.0209 | 0.0767 |
Trypanosoma brucei | cysteine peptidase C (CPC) | 0.0049 | 0.0319 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.3313 | 0.3462 |
Echinococcus granulosus | cathepsin b | 0.0148 | 0.2724 | 0.2724 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0044 | 0.0209 | 0.0767 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0044 | 0.0209 | 0.0767 |
Schistosoma mansoni | calpain-7 (C02 family) | 0.0044 | 0.0209 | 0.0767 |
Echinococcus granulosus | calpain A | 0.0044 | 0.0209 | 0.0209 |
Brugia malayi | calpain family protein 1 | 0.0117 | 0.1983 | 0.2073 |
Loa Loa (eye worm) | runx1 | 0.0054 | 0.0443 | 0.0463 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0148 | 0.2724 | 1 |
Giardia lamblia | Cathepsin B precursor | 0.0049 | 0.0319 | 0.5 |
Schistosoma mansoni | calpain (C02 family) | 0.0044 | 0.0209 | 0.0767 |
Schistosoma mansoni | Mername-AA248 (C02 family) | 0.0044 | 0.0209 | 0.0767 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.0044 | 0.0209 | 0.0767 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0148 | 0.2724 | 1 |
Echinococcus granulosus | calpain A | 0.0123 | 0.2112 | 0.2112 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0148 | 0.2724 | 1 |
Echinococcus granulosus | neuropeptide receptor A26 | 0.0448 | 1 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0223 | 0.4554 | 0.5 |
Schistosoma mansoni | calpain C (C02 family) | 0.0044 | 0.0209 | 0.0767 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0117 | 0.1983 | 0.2073 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0123 | 0.2112 | 0.7754 |
Echinococcus granulosus | calpain 7 C02 family | 0.0044 | 0.0209 | 0.0209 |
Schistosoma mansoni | lozenge | 0.0054 | 0.0443 | 0.1627 |
Echinococcus multilocularis | neuropeptide receptor A26 | 0.0448 | 1 | 1 |
Brugia malayi | cathepsin B-like cysteine proteinase | 0.0148 | 0.2724 | 0.2847 |
Loa Loa (eye worm) | hypothetical protein | 0.0117 | 0.1983 | 0.2073 |
Loa Loa (eye worm) | hypothetical protein | 0.0104 | 0.166 | 0.1735 |
Echinococcus granulosus | calpain | 0.0044 | 0.0209 | 0.0209 |
Loa Loa (eye worm) | cathepsin B | 0.0049 | 0.0319 | 0.0333 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0044 | 0.0209 | 0.0767 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0049 | 0.0319 | 0.1171 |
Echinococcus multilocularis | calpain | 0.0044 | 0.0209 | 0.0209 |
Plasmodium vivax | calpain, putative | 0.0044 | 0.0209 | 1 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0044 | 0.0209 | 0.6553 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0044 | 0.0209 | 0.0767 |
Loa Loa (eye worm) | hypothetical protein | 0.0086 | 0.1232 | 0.1287 |
Brugia malayi | hypothetical protein | 0.043 | 0.957 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.043 | 0.957 | 1 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0086 | 0.1232 | 0.1287 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0044 | 0.0209 | 0.6553 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0123 | 0.2112 | 0.2112 |
Toxoplasma gondii | cathepsin B | 0.0049 | 0.0319 | 1 |
Echinococcus multilocularis | calpain A | 0.0123 | 0.2112 | 0.2112 |
Echinococcus multilocularis | cathepsin b | 0.0148 | 0.2724 | 0.2724 |
Echinococcus multilocularis | calpain 5 | 0.0044 | 0.0209 | 0.0209 |
Onchocerca volvulus | 0.0073 | 0.0909 | 0.0949 | |
Leishmania major | calpain, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0044 | 0.0209 | 0.6553 |
Echinococcus multilocularis | calpain family protein 1, d | 0.0086 | 0.1232 | 0.1232 |
Loa Loa (eye worm) | calpain | 0.0044 | 0.0209 | 0.0218 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0123 | 0.2112 | 0.7754 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 1.2 % | Inhibition of carrageenan-induced rat's paw edema (CPE) after peroral administration of 100 mg/kg dose. | ChEMBL. | 1552506 |
Inhibition (functional) | = 1.7 % | Inhibition of Zymosan-induced rat's paw edema(ZPE) after peroral administration of 100 mg/kg dose. | ChEMBL. | 1552506 |
Inhibition (functional) | = 22.1 % | Compound was tested for the inhibition of rat reversed passive Arthus pleurisy after peroral administration of 100 mg/kg dose at 1.69*10e6 no of cells with 2.17*10e6 cells of control | ChEMBL. | 1552506 |
Inhibition (functional) | = 32.4 % | Compound was tested for the inhibition of rat reversed passive Arthus pleurisy after peroral administration of 100 mg/kg dose at 0.33 mL of exudate volume with 0.46 mL of control (injected intrapleurally) | ChEMBL. | 1552506 |
Swelling (functional) | = 51.3 % | Antiinflammatory activity of the compound on Zymosan-induced rat's paw edema(ZPE) after peroral administration of 100 mg/kg dose with control swelling of 52.2% | ChEMBL. | 1552506 |
Swelling (functional) | = 80.8 % | Antiinflammatory activity of the compound on Carrageenan rat's paw edema(CPE) after peroral administration of 100 mg/kg dose with control swelling of 81.0% | ChEMBL. | 1552506 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.